U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07677787) titled 'DLL3-Targeted PET/CT in Small Cell Lung Cancer' on June 08.
Brief Summary: The objective of the study is to evaluate the diagnostic value of DLL3-targeted PET/CT in patients with suspected or histologically confirmed small cell lung cancer, and to compare with conventional imaging modalities.
Study Start Date: May 09
Study Type: INTERVENTIONAL
Condition:
PET/CT
Small Cell Lung Cancer ( SCLC )
DLL3-targeted PET/CT
Delta-like Protein 3
Intervention:
DIAGNOSTIC_TEST: conventional imaging (CT, MRI or 18F-FDG PET/CT), DLL3-targeted PET/CT
Participants will undergo DLL3-Targeted PET/CT imaging for the evaluation of tumor lesions. Im...